Shanmuganathan, N., Yeung, D. T., Wadham, C., Fernandes, A., Maqsood, M., Shahrin, N., Saunders, V., Kenyon, R. R., Lin, M., Toubia, J., McConnell, J., Kaczorowski, D., Ross, D. M., Yong, A. S. M., Chee, L., Shortt, J., Viiala, N., Braley, J., Kok, C. H., Hughes, T. P., Branford, S. (2025). Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations. Blood. https://doi.org/10.1182/blood.2025030259